Ani Pharmaceuticals (ANIP) Profit After Tax (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Profit After Tax of $29.5 million for Q1 2026, up 7.28% sequentially from $27.5 million in Q4 2025, and up 88.07% YoY from $15.7 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Profit After Tax (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Profit After Tax for 17 years, with the latest figure at $29.5 million in Q1 2026.
- Quarterly Profit After Tax rose 88.07% year-over-year to $29.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.1 million (up 537.8% YoY) and the FY2025 annual result came in at $78.3 million, up 522.94% from the prior year.
- Profit After Tax climbed to $29.5 million in Q1 2026 per ANIP's latest filing, from $27.5 million in the prior quarter.
- Over five years, Profit After Tax peaked at $29.5 million in Q1 2026 and troughed at -$24.2 million in Q3 2024.
- A 5-year average of $3.5 million and a median of $1.4 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax tumbled 23977.91% in 2022, then surged 1165.25% in 2024.
- Over 5 years, Profit After Tax stood at -$4.2 million in 2022, then soared by 127.22% to $1.2 million in 2023, then slumped by 989.7% to -$10.3 million in 2024, then jumped by 367.52% to $27.5 million in 2025, then rose by 7.28% to $29.5 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $29.5 million, $27.5 million, and $26.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 24.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.71 Mn |
| Mar 31, 2026 | 29.49 Mn |
| Dec 31, 2025 | 27.49 Mn |
| Sep 30, 2025 | 26.62 Mn |
| Jun 30, 2025 | 8.55 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | -10.28 Mn |
| Sep 30, 2024 | -24.17 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | 18.21 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 9.94 Mn |
| Jun 30, 2023 | 6.25 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | -4.24 Mn |
| Sep 30, 2022 | -8.60 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | -20.54 Mn |
| Dec 31, 2021 | -24.14 Mn |
| Sep 30, 2021 | -4.45 Mn |